Nucl Med Mol Imaging.  2017 Sep;51(3):217-226. 10.1007/s13139-016-0446-5.

Potential Clinical Applications of ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Mammography in Breast Cancer

Affiliations
  • 1Department of Nuclear Medicine, Yeugnam University Hospital, 317-1, Daemyung-dong,Nam-gu, Daegu 705-717, Republic of Korea. Ihcho@med.yu.ac.kr

Abstract

The whole-body positron emission tomography (PET)/magnetic resonance (MR) scan is a cutting edge technology providing comprehensive structural information from MR imaging and functional features from PET in a single session. Recent research findings and clinical experience have shown that ¹â¸F-fluorodeoxyglucose (FDG) whole-body PET/MRimaging has a diagnostic performance comparable with or superior to that of PET/CT in the field of oncology, including for breast cancer. In particular, FDG PET/MR mammography in the prone position with the breast hanging in a pendant manner can provide more comprehensive information about the metabolism, anatomy, and functional features of a breast lesion than a whole-body PET/MR scan. This article reports on current state-of-the-art PET/MR mammography in patients with breast cancer and the prospects for potential application in the future.

Keyword

PET/MR; FDG; Breast cancer; Staging; Lymphaticmetastasis; Attenuation correction

MeSH Terms

Breast Neoplasms*
Breast*
Electrons*
Humans
Magnetic Resonance Imaging
Mammography*
Metabolism
Positron-Emission Tomography
Positron-Emission Tomography and Computed Tomography
Prone Position
Full Text Links
  • NMMI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error